Alberto Monroy-García

11PUBLICATIONS
37CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Dental therapeutics, pharmacology and toxicologySolid tumoursCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Oct 16, 2025
Interaction Between Mesenchymal Stromal Cells and Tumor Cells Present in Cervical Cancer Influences Macrophage Polarization.

Eduardo Bautista-Sebastián, Víctor Adrián Cortés-Morales, Guadalupe Rosario Fajardo-Orduña

|Mar 27, 2025
TGF-β Induces the Secretion of Extracellular Vesicles Enriched with CD39 and CD73 from Cervical Cancer Cells.

Gabriela Molina-Castillo, Alberto Monroy-García, Rosario García-Rocha

|Sep 14, 2024
Mesenchymal Stem/Stromal Cells Derived from Dental Tissues Mediate the Immunoregulation of T Cells through the Purinergic Pathway.

Luis Ignacio Poblano-Pérez, Alberto Monroy-García, Gladis Fragoso-González

|Apr 13, 2024
Adenosine increases PD-L1 expression in mesenchymal stromal cells derived from cervical cancer through its interaction with A2AR/A2BR and the production of TGF-β1.

Luis Antonio Marín-Aquino, María de Lourdes Mora-García, Martha C Moreno-Lafont

|Apr 13, 2023
Mesenchymal Stem/Stromal Cells Derived from Cervical Cancer Promote M2 Macrophage Polarization.

Víctor Adrián Cortés-Morales, Luis Chávez-Sánchez, Leticia Rocha-Zavaleta

|Feb 27, 2023
Inhibition of CD73 expression or A2AR blockade reduces MRP1 expression and increases the sensitivity of cervical cancer cells to cisplatin.

Monserrat Carrera-Martínez, María de L Mora-García, Rosario García-Rocha

Pageof 2